Literature DB >> 7139619

Carcinogenicity of N-nitrosodiethanolamine in rats at five different dose levels.

R Preussmann, M Habs, H Habs, D Schmähl.   

Abstract

N-nitrosodiethanolamine, an N-nitroso compound of environmental significance, has been tested for carcinogenicity in male Sprague-Dawley rats at five different dose levels. Administration p.o. in the drinking water of 1.5, 6, 25, 100, or 400 mg N-nitrosodiethanolamine per kg per day was tolerated well. Median total doses administered were between 0.86 g/kg body weight at the highest and 100.3 g/kg body weight at the lowest dose level. Treatment-related tumors were observed in the liver and the nasal cavity. The induction of hepatocellular carcinomas was clearly dose related, low doses also inducing benign lesions. Other liver tumors were of mesenchymal and ductal origin and nasal cavity neoplasms were diagnosed as squamous-cell carcinomas and neuroepitheliomas of the olfactory epithelium. Statistical evaluation of the 1.5-mg/kg dose regimen clearly indicates that even such low doses are carcinogenic. This potent carcinogenic activity is surprising since a high percentage (60 to 90%) of an administered dose of N-nitrosodiethanolamine is excreted unchanged in the urine. Thus, we propose that an as yet unidentified metabolite may possess high carcinogenic potential.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139619

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Increased mutagenicity of N-nitrosodiethanolamine in human lymphocyte cultures after activation by alcohol dehydrogenase.

Authors:  I Henn; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 2.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Prediction of rodent carcinogenicity of further 30 chemicals bioassayed by the U.S. National Toxicology Program.

Authors:  R Benigni; C Andreoli; R Zito
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

4.  Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.

Authors:  G Eisenbrand; E Denkel; B Pool
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 5.  Carcinogenic N-nitroso compounds and their environmental significance.

Authors:  R Preussmann
Journal:  Naturwissenschaften       Date:  1984-01

6.  Studies on the metabolic activation of diethanolnitrosamine in animal-mediated and in vitro assays using Escherichia coli K-12 343/113 as an indicator.

Authors:  S Knasmüller; G Stehlik; G Mohn
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  N-nitrosodiethanolamine is activated in the rat to an ultimate genotoxic metabolite by sulfotransferase.

Authors:  W Sterzel; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Cytogenetic effects of N-nitrosodiethanolamine (NDELA) and NDELA-monoacetate in human lymphocytes.

Authors:  U Dittberner; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Biological monitoring of workers exposed to N-nitrosodiethanolamine in the metal industry.

Authors:  S Monarca; G Scassellati-Sforzolini; F Donato; G Angeli; B Spiegelhalder; C Fatigoni; R Pasquini
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

Review 10.  Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982.

Authors:  L S Gold; M de Veciana; G M Backman; R Magaw; P Lopipero; M Smith; M Blumenthal; R Levinson; L Bernstein; B N Ames
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.